A detailed history of Compagnie Lombard Odier S Cm A transactions in Eli Lilly & CO stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 127,649 shares of LLY stock, worth $104 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
127,649
Previous 71,364 78.87%
Holding current value
$104 Million
Previous $63.2 Million 55.87%
% of portfolio
1.54%
Previous 1.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$727.2 - $932.06 $40.9 Million - $52.5 Million
56,285 Added 78.87%
127,649 $98.5 Million
Q3 2024

Oct 11, 2024

BUY
$772.14 - $960.02 $4.25 Million - $5.28 Million
5,498 Added 8.35%
71,364 $63.2 Million
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $7.27 Million - $9.12 Million
10,031 Added 17.97%
65,866 $59.6 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $8.63 Million - $11.5 Million
14,574 Added 35.32%
55,835 $43.4 Million
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $12.5 Million - $14.8 Million
23,883 Added 137.43%
41,261 $24.1 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $4.84 Million - $6.67 Million
11,134 Added 178.32%
17,378 $9.33 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $1.04 Million - $1.39 Million
2,958 Added 90.02%
6,244 $2.93 Million
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $500,424 - $587,725
1,611 Added 96.18%
3,286 $1.13 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $255,632 - $297,862
795 Added 90.34%
1,675 $612,000
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $147,054 - $167,583
-496 Reduced 36.05%
880 $284,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $100,342 - $117,817
360 Added 35.43%
1,376 $446,000
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $44,356 - $55,123
-189 Reduced 15.68%
1,016 $291,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $67,455 - $83,712
300 Added 33.15%
1,205 $333,000
Q1 2021

Apr 23, 2021

SELL
$164.32 - $212.72 $139,672 - $180,812
-850 Reduced 48.43%
905 $169,000
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $228,957 - $302,965
1,755 New
1,755 $296,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $0 - $0
0 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $48,220 - $59,725
-451 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $48,162 - $52,388
451 New
451 $50,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $88,632 - $103,456
-800 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $33,485 - $41,850
390 Added 95.12%
800 $86,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $114,797 - $123,133
-1,401 Reduced 77.36%
410 $35,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,811
1,811 $149,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.